AU Patent

AU2014218455B2 — Ferric Citrate Dosage Forms

Assigned to Keryx Biopharmaceuticals Inc · Expires 2016-11-24 · 9y expired

What this patent protects

The disclosure relates to ferric citrate tablets and dosage forms. - 37 - HARDNESS VS. COMPRESSION FORCE 20.0-/ 5. Formnulation 3 -0-- Formulation 4 --A-- Formulation 4 -- Formulation 5 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 COMPRESSION FORCE

USPTO Abstract

The disclosure relates to ferric citrate tablets and dosage forms. - 37 - HARDNESS VS. COMPRESSION FORCE 20.0-/ 5. Formnulation 3 -0-- Formulation 4 --A-- Formulation 4 -- Formulation 5 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 COMPRESSION FORCE

Drugs covered by this patent

Patent Metadata

Patent number
AU2014218455B2
Jurisdiction
AU
Classification
—
Expires
2016-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Keryx Biopharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.